Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-09-30
2008-11-25
Desai, Rita (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S300000
Reexamination Certificate
active
07456286
ABSTRACT:
A series of 5-6 fused ring bicyclic heteroaromatic derivatives, based in particular on the 5-oxo-4,5-dihydro-1H-pyrrolo[3,2-b]pyridine ring system, being inhibitors of p38 kinase, are accordingly of use in medicine, for example in the treatment and/or prevention of immune or inflammatory disorders.
REFERENCES:
patent: 7176215 (2007-02-01), Davis et al.
patent: 2006/0025428 (2006-02-01), Brookings et al.
Andresen et al Tetrahedron 52, 12979-12992.
Brookings Daniel Christopher
Cubbon Rachel Jane
Davis Jeremy Martin
Langham Barry John
Desai Rita
Mabry John
McDonnell Boehnen & Hulbert & Berghoff LLP
UCB Pharma S.A.
LandOfFree
Bicyclic heteroaromatic compounds as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic heteroaromatic compounds as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic heteroaromatic compounds as kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4034351